Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma - Quiz - MDSpire

Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma

  • By

  • Lin Zhu

  • Die Zhang

  • Jie Chen

  • Wei Qian

  • Peiyao Liu

  • Chunying Shen

  • Tingting Xu

  • Xin Zhou

  • Xueguan Lu

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma

  • by Lin Zhu, Die Zhang, Jie Chen, Wei Qian, Peiyao Liu, Chunying Shen, Tingting Xu, Xin Zhou, Xueguan Lu

  • June 11, 2026

Related Content

Development and validation of an interpretable machine learning model for predicting 5-year recurrence in breast cancer

Survival benefit of extended lymphadenectomy in endometrial cancer: a meta-analysis with risk-stratified subgroup analysis

Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer